Mechanisms of beta adrenoceptor desensitisation in the failing human heart.

作者信息

Harding S E, Brown L A, Wynne D G, Davies C H, Poole-Wilson P A

机构信息

Department of Cardiac Medicine, National Heart and Lung Institute, London, United Kingdom.

出版信息

Cardiovasc Res. 1994 Oct;28(10):1451-60. doi: 10.1093/cvr/28.10.1451.

DOI:10.1093/cvr/28.10.1451

PMID:8001031

Abstract

摘要

相似文献

Mechanisms of beta adrenoceptor desensitisation in the failing human heart.

Cardiovasc Res. 1994 Oct;28(10):1451-60. doi: 10.1093/cvr/28.10.1451.

Experimental heart failure in rats: effects on cardiovascular circadian rhythms and on myocardial beta-adrenergic signaling.

Cardiovasc Res. 2000 Aug;47(2):350-8. doi: 10.1016/s0008-6363(00)00099-7.

Alterations of beta-adrenoceptor-G-protein-regulated adenylyl cyclase in heart failure.

Mol Cell Biochem. 1995;147(1-2):147-60.

Beta-adrenergic receptors in failing human myocardium.

Basic Res Cardiol. 1996;91 Suppl 2:35-40. doi: 10.1007/BF00795360.

Beta-adrenergic hormone-receptor interactions in the hypertrophied and failing myocardium.

Eur Heart J. 1984 Dec;5 Suppl F:329-37. doi: 10.1093/eurheartj/5.suppl_f.329.

The molecular basis for distinct beta-adrenergic receptor subtype actions in cardiomyocytes.

Circ Res. 1999 Nov 26;85(11):1101-11. doi: 10.1161/01.res.85.11.1101.

Beta-adrenoceptor blocker treatment and the cardiac beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in chronic heart failure.

Naunyn Schmiedebergs Arch Pharmacol. 2007 Feb;374(5-6):361-72. doi: 10.1007/s00210-006-0125-7. Epub 2007 Jan 11.

Beta-adrenergic function in heart muscle disease and heart failure.

J Mol Cell Cardiol. 1985 Jul;17 Suppl 2:41-52. doi: 10.1016/0022-2828(85)90007-0.

[Alterations in myocardial adrenoceptor transduction systems in health and disease].

Kokyu To Junkan. 1991 Apr;39(4):311-9.

Localization of a "postreceptor" defect in human dilated cardiomyopathy.

Am J Cardiol. 1989 Oct 1;64(12):812-4. doi: 10.1016/0002-9149(89)90773-x.

引用本文的文献

Altering Calcium Sensitivity in Heart Failure: A Crossroads of Disease Etiology and Therapeutic Innovation.

Int J Mol Sci. 2023 Dec 17;24(24):17577. doi: 10.3390/ijms242417577.

Hypertrophic Cardiomyopathy: A Vicious Cycle Triggered by Sarcomere Mutations and Secondary Disease Hits.

Antioxid Redox Signal. 2019 Aug 1;31(4):318-358. doi: 10.1089/ars.2017.7236. Epub 2018 Apr 11.

Cardiomyocyte Hypocontractility and Reduced Myofibril Density in End-Stage Pediatric Cardiomyopathy.

Front Physiol. 2017 Dec 22;8:1103. doi: 10.3389/fphys.2017.01103. eCollection 2017.

Genotype-specific pathogenic effects in human dilated cardiomyopathy.

J Physiol. 2017 Jul 15;595(14):4677-4693. doi: 10.1113/JP274145. Epub 2017 Jun 1.

Impaired norepinephrine regulation of monocyte inflammatory cytokine balance in heart failure.

World J Cardiol. 2016 Oct 26;8(10):584-589. doi: 10.4330/wjc.v8.i10.584.

Decreased beta-adrenergic responsiveness following hypertrophy occurs only in cardiomyocytes that also re-express beta-myosin heavy chain.

Eur J Heart Fail. 2009 Jul;11(7):648-52. doi: 10.1093/eurjhf/hfp073.

Myofilament dysfunction in cardiac disease from mice to men.

J Muscle Res Cell Motil. 2008;29(6-8):189-201. doi: 10.1007/s10974-008-9160-y. Epub 2009 Jan 13.

Effects of autologous bone marrow stem cell transplantation on beta-adrenoceptor density and electrical activation pattern in a rabbit model of non-ischemic heart failure.

J Cardiothorac Surg. 2006 Jun 26;1:17. doi: 10.1186/1749-8090-1-17.

Mitral valve reconstruction in the patient with heart failure.

Heart Fail Rev. 2001 Sep;6(3):177-85. doi: 10.1023/a:1011421014480.

The effect of Gi-protein inactivation on basal, and beta(1)- and beta(2)AR-stimulated contraction of myocytes from transgenic mice overexpressing the beta(2)-adrenoceptor.

Br J Pharmacol. 2000 Oct;131(3):594-600. doi: 10.1038/sj.bjp.0703591.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验